<-- Back to proposed bills
Covid-19 Update
07 February 2024
Type
Written Ministerial Statement
Department
Department of Health and Social Care
At a Glance
Issue Summary
The statement addresses the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI) regarding the spring 2024 COVID-19 vaccination programme.
Action Requested
HM Government has accepted JCVI's advice to offer a further dose of the latest XBB-variant vaccines in spring 2024 to those at greatest risk, with all four parts of the UK intending to follow this guidance. The statement also notes that HMG is updating liabilities for vaccine deployment and considering cost-effectiveness in future programmes.
Key Facts
- JCVI advises offering a further dose of COVID-19 vaccines in spring 2024 to those aged 75 years and above.
- The minimum gap between doses should be around 6 months after the last vaccine dose with a minimum interval of 3 months.
- XBB-variant and mRNA Omicron XBB.1.5 vaccines are considered most cost-effective for use in spring 2024.
▸
Assessment & feedback
Summary accuracy